Table 1 Baseline clinical characteristics.
Characteristic | All | Up-front strategy | Bailout strategy | P-value |
|---|---|---|---|---|
Age | 63.9 ± 12.3 | 64.2 ± 12.4 | 63.7 ± 12.2 | 0.611 |
Male | 352 (76.7) | 164 (78.1) | 188 (75.5) | 0.513 |
Length of stay (days) | 5.02 ± 10.0 | 4.44 ± 5.11 | 5.51 ± 12.76 | 0.254 |
Use of GpIIbIIIa | 167 (36.4) | 127 (60.5) | 40 (16.1) | < 0.001 |
Diabetes mellitus (DM) | 104 (22.7) | 55 (26.2) | 49 (19.7) | 0.097 |
Hypertension (HTN) | 231 (50.3) | 105 (50.0) | 126 (50.6 | 0.898 |
Uncontrolled HTN at admission (SBP > 160 mmHg) | 14 (3.1) | 10 (4.8) | 4 (1.6) | 0.05 |
Stroke | 33 (7.2) | 15 (7.1) | 18 (7.2) | 0.972 |
Vascular disease | 79 (17.2) | 31 (14.8) | 48(19.3) | 0.202 |
Heart failure | 17 (3.7) | 10 (4.8) | 7 (2.8) | 0.27 |
Chronic kidney disease (CKD) | 33 (7.5) | 16 (7.6) | 17 (6.8) | 0.744 |
Chronic liver disease | 7 (1.5) | 0 | 7 (2.8) | 0.014 |
History of previous major bleeding | 35 (7.6) | 10 (4.8) | 25 (10.0) | 0.034 |
History of labile INR | 5 (1.1) | 0 | 5 (2.0) | 0.039 |
Drugs associated with increased risk of bleeding* | 79 (17.2) | 51 (24.3) | 28 (11.2) | < 0.001 |
Alcoholism | 46 (10.0) | 19 (9.1) | 27 (10.8) | 0.534 |
Height (m) | 1.71 ± 0.09 | 1.71 ± 0.10 | 1.71 ± 0.09 | 0.538 |
Weight (kg) | 79.2 ± 18.0 | 80.9 ± 20.3 | 77.9 ± 15.9 | 0.102 |
BMI (kg/m2) | 26.8 ± 6.3 | 26.7 ± 4.7 | 25.6 ± 7.4 | 0.06 |
Creatinine (mmol/L) | 89.1 ± 42.5 | 89.1 ± 49.4 | 89.1 ± 35.7 | 0.987 |
